KAT6A Antibody Market: How Is Rare Disease Research Driving KAT6A...

added blog Botanik

2026-06-01 09:02:02

KAT6A Antibody Market: How Is Rare Disease Research Driving KAT6A Antibody Demand?

Rare disease research driving KAT6A antibody market development — the growing scientific investigation of KAT6A syndrome — a rare neurodevelopmental disorder caused by pathogenic variants in the KAT6A gene (encoding lysine acetyltransferase 6A, also known as MOZ or MYST3) — where affected individuals present with intellectual disability, speech delay, cardiac defects, feeding...

0 Comments 0 Shares 24 Views 0 Reviews